Shamai Carter

Shamai Carter serves as a key procurement lead at the Naval Medical Research Center, supporting the agency’s mission to enhance the operational readiness of Navy and Marine Corps personnel through advanced biomedical innovation. Responsible for managing complex acquisitions in diagnostic and analytical instrumentation, Carter oversees the procurement of laboratory-grade equipment and field-deployable medical technologies designed for austere environments. Their work directly enables the development and validation of rapid pathogen detection systems, precision monitoring tools, and other force health protection capabilities critical to expeditionary medical operations. Carter’s portfolio is narrowly focused on high-precision analytical instruments requiring stringent technical compliance and validation protocols. Carter maintains a consistent and long-standing partnership with REES SCIENTIFIC CORPORATION, a specialized vendor with demonstrated expertise in manufacturing custom analytical laboratory instrumentation tailored to military medical needs. This relationship reflects a preference for established technical partners capable of meeting rigorous DoD specifications for durability, portability, and biological safety. The contracting pattern indicates a reliance on proven suppliers with deep domain knowledge in biomedical instrumentation, rather than broad market competitions, suggesting a focus on mission-critical performance over price-based selection. Carter’s procurement activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical capability and rapid delivery over socioeconomic preferences, consistent with the urgent operational needs of force health protection programs. While small business participation is not formally incentivized, the agency’s reliance on niche manufacturers may inadvertently support specialized small firms with unique engineering capabilities. The primary NAICS classification for all acquisitions is 334516—Analytical Laboratory Instrument Manufacturing—indicating an exclusive focus on high-end diagnostic equipment such as PCR analyzers, mass spectrometers, biosensors, and point-of-care diagnostic platforms. Carter’s expertise lies in procuring scientifically validated, ruggedized instruments that meet military standards for deployment in shipboard, forward-deployed, and remote field settings, ensuring reliable performance under extreme environmental conditions.